Zi Diligence

  • Overview

Zi Diligence is a leading Contract Research Organization (CRO) based in Egypt, designed to provide specialized clinical and bioanalytical services to the pharmaceutical industry.

 It serves as an essential scientific partner, offering a comprehensive repository of services—from bioavailability/bioequivalence studies to clinical trials—that bridge the gap between drug development and regulatory approval.

The project’s mission is to deliver exceptional quality and scientifically robust data, adhering to global standards (GCP/GLP) to support its clients in bringing new and generic drugs to market.

  • Features
  • Built with custom WordPress theme and structure.
  • Fully responsive design for all screen sizes.
  • Clean and SEO-friendly URL structure.
  • Easy-to-use admin panel for content management.
  • Offers a full suite of services, including bioequivalence studies and clinical trials.
  • Holds key accreditations from the Egyptian MOH, GCC, and ISO certifications.
  • Possesses extensive experience, having conducted over 250 successful studies.
  • Employs a highly specialized team to ensure efficient and accurate project management.
  • Trusted by hundreds of multinational, international, and national pharmaceutical companies.
  • Audience
Zi Diligence is designed for pharmaceutical companies, ranging from large multinational corporations to national and international drug manufacturers. The platform serves as a critical resource for any pharmaceutical entity requiring expert, accredited research services to support the development, registration, and marketing of their medicinal products.
  • Share project: